Trade VOR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Vor Biopharma Inc. (VOR) is trading at US$19.79, up 6.07% today as of Nov 6, 15:04 EST. The company has a market capitalisation of US$1.38B. Over the past 52 weeks, VOR has traded between US$6.50 and US$26.00. On Syfe you can trade VOR with $0 commission and add it to your watchlist.
| Previous close | US$18.66 |
|---|---|
| Market cap | US$1.38B |
| 52-week range | US$6.50 – US$26.00 |
| Volume | 629.66K |
| Exchange | US |
Vor Biopharma Inc.
Vor Biopharma, Inc. is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. It is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.
Year: 2021
Vor Biopharma Completes Enrollment in Phase 3 Trial of Investigational Drug for Generalized Myasthenia Gravis
Sep 8, 11:46 AM · MT Newswires
Wedbush Adjusts Price Target on Vor Biopharma to $27 From $18, Keeps Neutral Rating
Aug 11, 2:58 PM · MT Newswires
Vor Biopharma Shares Drop After Q2 Results
Aug 11, 2:05 PM · MT Newswires
Vor Biopharma Inc. (VOR) stock is trading at US$19.79, +6.07% from the previous close of US$18.66.
The market cap for Vor Biopharma Inc. (VOR) stock is approximately US$1.38B.
The 52-week high for Vor Biopharma Inc. (VOR) stock is US$26.00.
The 52-week low for Vor Biopharma Inc. (VOR) stock is US$6.50.
Vor Biopharma Inc. (VOR) does not currently pay a dividend.
Stay on top of VOR
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
